Literature DB >> 21691299

The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling.

Li-wei Dong1, Guang-zhen Yang, Yu-fei Pan, Yao Chen, Ye-xiong Tan, Rong-yang Dai, Yi-bin Ren, Jing Fu, Hong-yang Wang.   

Abstract

p28(GANK) (also known as PSMD10 or gankyrin) is a novel oncoprotein that is highly expressed in hepatocellular carcinoma (HCC). Through its interaction with various proteins, p28(GANK) mediates the degradation of the tumor suppressor proteins Rb and p53. Although p53 was reported to downregulate β-catenin, whether p28(GANK) is involved in the regulation of β-catenin remains uncertain. Here we report that both growth factors and Ras upregulate p28(GANK) expression through the activation of the phosphoinositide 3-kinase-AKT pathway. Upregulation of p28(GANK) expression subsequently enhanced the transcription activity of β-catenin. This effect was observed in p53-deficient cells, suggesting a p53-independent mechanism for the p28(GANK)-mediated activation of β-catenin. p28(GANK) overexpression also reduced E-cadherin protein levels, leading to increased release of free β-catenin into the cytoplasm from the cadherin-bound pool. Interestingly, exogenous expression of p28(GANK) resulted in elevated expression of the endogenous protein. We also observed that both β-catenin and c-Myc were transcriptional activators of p28(GANK), and a correlation between p28(GANK) overexpression and c-Myc, cyclin D1 and β-catenin activation in primary human HCC. Together, these results suggest that p28(GANK) expression is regulated by a positive feedback loop involving β-catenin, which may play a critical role in tumorigenesis and the progression of HCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21691299      PMCID: PMC3193485          DOI: 10.1038/cr.2011.103

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  38 in total

Review 1.  Genetics of hepatocellular carcinoma.

Authors:  M A Buendia
Journal:  Semin Cancer Biol       Date:  2000-06       Impact factor: 15.707

Review 2.  The Hedgehog and Wnt signalling pathways in cancer.

Authors:  J Taipale; P A Beachy
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.

Authors:  C M Wong; S T Fan; I O Ng
Journal:  Cancer       Date:  2001-07-01       Impact factor: 6.860

4.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.

Authors:  S Satoh; Y Daigo; Y Furukawa; T Kato; N Miwa; T Nishiwaki; T Kawasoe; H Ishiguro; M Fujita; T Tokino; Y Sasaki; S Imaoka; M Murata; T Shimano; Y Yamaoka; Y Nakamura
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

Review 5.  Signalling networks that cause cancer.

Authors:  F McCormick
Journal:  Trends Cell Biol       Date:  1999-12       Impact factor: 20.808

Review 6.  GSK3 takes centre stage more than 20 years after its discovery.

Authors:  S Frame; P Cohen
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

7.  Down-regulation of beta-catenin by activated p53.

Authors:  E Sadot; B Geiger; M Oren; A Ben-Ze'ev
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

8.  Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.

Authors:  Satoshi Inagawa; Masayuki Itabashi; Shinya Adachi; Toru Kawamoto; Masao Hori; Jiro Shimazaki; Fuyo Yoshimi; Katashi Fukao
Journal:  Clin Cancer Res       Date:  2002-02       Impact factor: 12.531

9.  cDNA cloning and functional analysis of p28 (Nas6p) and p40.5 (Nas7p), two novel regulatory subunits of the 26S proteasome.

Authors:  T Hori; S Kato; M Saeki; G N DeMartino; C A Slaughter; J Takeuchi; A Toh-e; K Tanaka
Journal:  Gene       Date:  1998-08-17       Impact factor: 3.688

10.  Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.

Authors:  Y Kondo; Y Kanai; M Sakamoto; T Genda; M Mizokami; R Ueda; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1999-12
View more
  17 in total

Review 1.  Gankyrin as a potential target for tumor therapy: evidence and perspectives.

Authors:  Haixai Li; Junyan Zhang; Cheng Zhen; Baojun Yang; Limin Feng
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 2.  Gankyrin as a potential therapeutic target for cancer.

Authors:  Chongchong Wang; Li Cheng
Journal:  Invest New Drugs       Date:  2017-05-19       Impact factor: 3.850

3.  Pleiotropic roles of FXR in liver and colorectal cancers.

Authors:  Xiongfei Huang; Mingjie Fan; Wendong Huang
Journal:  Mol Cell Endocrinol       Date:  2022-01-04       Impact factor: 4.102

4.  Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.

Authors:  J Chen; M Bai; C Ning; B Xie; J Zhang; H Liao; J Xiong; X Tao; D Yan; X Xi; X Chen; Y Yu; R C Bast; Z Zhang; Y Feng; W Zheng
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

5.  MiR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway.

Authors:  Ya-Fei Zhang; An-Ran Zhang; Bi-Cheng Zhang; Zhi-Guo Rao; Jian-Fei Gao; Mu-Han Lv; Yu-Yun Wu; Su-Min Wang; Rong-Quan Wang; Dian-Chun Fang
Journal:  Mol Biol Rep       Date:  2012-10-30       Impact factor: 2.316

6.  Association of gankyrin and stemness factor expression in human colorectal cancer.

Authors:  Hiromasa Mine; Toshiharu Sakurai; Hiroshi Kashida; Shigenaga Matsui; Naoshi Nishida; Tomoyuki Nagai; Satoru Hagiwara; Tomohiro Watanabe; Masatoshi Kudo
Journal:  Dig Dis Sci       Date:  2013-03-19       Impact factor: 3.199

Review 7.  Gankyrin regulates cell signaling network.

Authors:  Xinxin Wang; Bin Jiang; Yanjie Zhang
Journal:  Tumour Biol       Date:  2016-01-27

8.  p28GANK overexpression is associated with chemotherapy resistance and poor prognosis in ovarian cancer.

Authors:  Ge Yu; Na Li; Wei Wang; Ming Niu; Xiaoling Feng
Journal:  Oncol Lett       Date:  2019-11-13       Impact factor: 2.967

9.  Prognostic value of carbonic anhydrase VII expression in colorectal carcinoma.

Authors:  Guang-Zhen Yang; Liang Hu; Jian Cai; Hai-Yang Chen; Yu Zhang; Dan Feng; Chen-Ye Qi; Yan-Xia Zhai; Hui Gong; Hao Fu; Qing-Ping Cai; Chun-Fang Gao
Journal:  BMC Cancer       Date:  2015-04-01       Impact factor: 4.430

10.  Gankyrin gene deletion followed by proteomic analysis: insight into the roles of Gankyrin in tumorigenesis and metastasis.

Authors:  Xue Luo; Liang Chen; Jiang Dai; Yanfei Gao; Hongli Wang; Na Wang; Yongqiang Zhao; Feng Liu; Zhihong Sang; Jie Wang; Weihua Li; Kun He; Baofeng Jin; Jianghong Man; Wei Zhang; Qing Xia
Journal:  BMC Med Genomics       Date:  2012-08-22       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.